Molecular basis for lack of expression of HLA class I antigens in human small-cell lung carcinoma cell lines
- 27 November 1996
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 68 (5) , 629-636
- https://doi.org/10.1002/(sici)1097-0215(19961127)68:5<629::aid-ijc13>3.0.co;2-x
Abstract
HLA class I molecules present antigenic peptides to cytotoxic T lymphocytes and thus play an important role in immune surveillance of cells infected with virus or altered by malignant transformation. Immunochemical studies have demonstrated a marked deficiency or lack of expression of class I molecules on the surface of many different types of tumor cells. It is likely that this allows these cells to escape immune surveillance. In the present study, we examined the molecular basis for lack of expression of class I antigens in small‐cell lung carcinoma cell lines. Our results demonstrate that these cell lines also lacked products of MHC‐encoded proteasome subunit LMP2 and the putative peptide transporter TAP1. In contrast, LMP7 and TAP2 genes were expressed in these cell lines. Pulse‐chase experiments showed that class I molecules were unstable and thus not transported to the cell surface from endoplasmic reticulum. Our results suggest that antigenic peptides were not available for binding to class I &agr: chains due to genes showed that the tumor cells lacked trans‐regulatory nuclear protein(s), which binds to the interferon‐γ (IFN‐γ) response element (ISRE) in the TAP I, LMP2 bidirectional intergenic promoter. Treatment of tumor cells with IFN‐γ induced ISRE‐binding nuclear protein(s) and resulted in expression of TAP 1 and LMP2 genes with a concomitant increase in cell‐surface expression of class I molecules. Our data provide credence for a role of TAP and LMP genes in immune response. © 1996 Wiley‐Liss, Inc.Keywords
This publication has 17 references indexed in Scilit:
- Markedly decreased expression of TAP1 and LMP2 genes in HLA class I-deficient human tumor cell linesImmunology Letters, 1996
- Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinial relevanceImmunology Today, 1995
- Comprehensive, serologically equivalent DNA typing for HLA‐B by PCR using sequence‐specific primers (PCR‐SSP)Tissue Antigens, 1995
- Major Histocompatibility-encoded Human Proteasome LMP2Published by Elsevier ,1995
- HLA expression in hepatocellular carcinoma cell linesClinical and Experimental Immunology, 1994
- Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas.The Journal of Experimental Medicine, 1994
- HLA CLASS I NON-CODING NUCLEOTIDE SEQUENCES, 1992European Journal of Immunogenetics, 1993
- Identification of human cancers deficient in antigen processing.The Journal of Experimental Medicine, 1993
- Antigen Recognition by Class I-Restricted T LymphocytesAnnual Review of Immunology, 1989
- Defective expression of MHC class I antigens is frequent in B‐cell lymphomas of high‐grade malignancyInternational Journal of Cancer, 1987